Lime (LIME) Q2 2026 earnings review
Record Revenue Shadowed by Surging Operating Expenses
In its first quarter as a public company, Lime reported a solid 24% YoY revenue increase to $304 million, driven by a 22% larger operational fleet. However, the headline $295 million Net Income is a mirage—it was entirely generated by a $298 million non-cash tax valuation allowance release. Beneath the surface, Operating Profit collapsed 69% to $12.8 million as SG&A and R&D expenses ballooned. Despite near-term margin compression, the company is guiding for accelerating momentum in Q3 and cleaned up its balance sheet by using IPO proceeds to eliminate all outstanding long-term debt.
🐂 Bull Case
Average operational fleet grew 22% YoY to 407,707 vehicles, maintaining a direct correlation with the 24% revenue growth. This indicates stable pricing and utilization (Revenue per Vehicle per Day) even as the footprint expands.
Lime used its IPO proceeds to pay down all outstanding long-term debt, which previously burdened the company with heavy interest and fair-value change expenses. This sets a foundation for cleaner future earnings.
🐻 Bear Case
Despite a $58 million increase in revenue, Operating Profit fell from $41.5 million in 25Q2 to just $12.8 million in 26Q2, highlighting severe negative operating leverage from ballooning overhead.
Aggressive capital expenditures ($75.7 million in Q2, up 116% YoY) drove Free Cash Flow reversing from +$52.3 million a year ago to -$4.1 million this quarter.
⚖️ Verdict: ⚪
Neutral. The top-line growth, debt elimination, and strong Q3 guidance are undeniably positive, but the dramatic spike in operating expenses and negative free cash flow make the core profitability narrative difficult to trust in the short term.
Key Themes
Severe Negative Operating Leverage
Lime's cost structure grew significantly faster than its revenue. SG&A expenses surged 68% YoY to $67.3 million, and R&D expenses skyrocketed 123% YoY to $31.2 million. Consequently, Total Operating Expenses consumed 38% of revenue, up from 27% a year ago. While some of this may be tied to public company readiness, it represents a reversing trend in operational efficiency.
Fleet Expansion Drives Top-Line Growth
The 24% YoY revenue growth was perfectly underpinned by physical scale: the Average Operational Fleet grew 22% YoY to 407,707 vehicles. Expanding the vehicle base remains the most reliable lever for Lime's top-line trajectory, provided unit economics stay stable.
Free Cash Flow Reversing to Negative
Free Cash Flow reversed sharply, falling from a healthy $52.3 million in 25Q2 to -$4.1 million in 26Q2. This was primarily driven by a massive step-up in capital expenditures, which more than doubled YoY to $75.7 million as the company aggressively scaled its fleet. Elevated CapEx is consuming operating cash entirely.
Canadian Market Consolidation
Subsequent to the quarter end, Lime acquired Neuron Mobility’s Canadian operations. This M&A move immediately expands operations in key cities and consolidates Lime's market share in a core North American geography.
Other KPIs
Decelerating. Adjusted Gross Margin (excluding depreciation) compressed by 360 basis points from 55.7% a year ago. Cost of revenue grew 28% YoY, outpacing the 24% revenue growth, suggesting higher direct operational costs or lower utilization per unit.
Stable to decelerating on a margin basis. While nominal Adjusted EBITDA grew 10.5% YoY, the margin compressed from 31.0% in 25Q2 to 27.7% in 26Q2. The adjustment strips out the massive non-cash tax benefit and heavy stock-based compensation ($38.1M) to reflect baseline profitability.
Guidance
Accelerating sequentially. The $350 million midpoint represents a robust 15% step-up from 26Q2's $304 million, indicating continued strong adoption through the peak summer riding season.
Accelerating. The $125 million midpoint implies a massive 48% sequential jump from Q2. This suggests management expects significant operating leverage to kick in during the high-revenue Q3, projecting margins to return to the ~35% range.
With H1 2026 revenue at $474.4 million, the $1.07 billion midpoint implies H2 2026 revenue of ~$596 million. This indicates stable, durable growth expected throughout the back half of the year.
With $132.6 million already spent in H1 2026, the guidance implies a dramatic deceleration in CapEx for the second half (only ~$50 million remaining). If accurate, this should allow Free Cash Flow to inflect positively in H2.
Key Questions
Operating Expense Normalization
SG&A and R&D expenses more than doubled their share of revenue YoY. How much of this was one-time IPO preparation versus a permanent structural shift in operating costs?
Capital Expenditure Timing
H1 CapEx consumed $132 million, leaving only ~$50 million for H2 based on your full-year guidance. Will the reduction in H2 CapEx directly translate into positive Free Cash Flow, or are there working capital headwinds expected?
Neuron Canada Integration
Regarding the acquisition of Neuron Mobility's Canadian operations: what is the expected timeline for integration, and how much margin drag should we model during the transition phase?